Showing 2,783 results

Filters Content type: News, Editors' picks Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

ICWEA Statement on Gilead’s announcement of twice-yearly Lenacapavir (LEN) for HIV prevention.

Editor's pick
International Community of Women living with HIV Eastern Africa
21 June 2024

HIV prevention drug uptake is slow. Can offering choices change that?

Editor's pick
Devex (requires free registration)
20 June 2024

U.S. Clinical Trials Begin for Twice-Yearly HIV Prevention Injection

Editor's pick
National Institute of Allergy and Infectious Diseases
4 June 2024

UK: New cabotegravir formulations approved to help prevent HIV-1 infection in adults and adolescents

Editor's pick
Medicines and Healthcare products Regulatory Agency (MHRA)
6 May 2024